Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

The introduction and subsequent widespread adaptation of minimally invasive approaches for bariatric surgery have not only changed the outcomes of bariatric surgery but also called into question the management of co-morbid surgical conditions, in particular gallbladder disease. The American Society for Metabolic and Bariatric Surgery Foregut Committee performed a systematic review of the published literature from 1995-2018 on management of gallbladder disease in patients undergoing bariatric surgery. The papers reviewed generated the following results. (1) Routine prophylactic cholecystectomy at the time of bariatric surgery is not recommended. (2) In symptomatic patients who are undergoing bariatric surgery, concomitant cholecystectomy is acceptable and safe. (3) Ursodeoxycholic acid may be considered for gallstone formation prophylaxis during the period of rapid weight loss. (4) Routine preoperative screening and postoperative surveillance ultrasound is not recommended in asymptomatic patients. In the era of minimally invasive surgery, the management of gallbladder disease in patients undergoing bariatric surgery continues to evolve. Copyright © 2019 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.


Adolfo Leyva-Alvizo, Gabriela Arredondo-Saldaña, Valeria Leal-Isla-Flores, John Romanelli, Ranjan Sudan, Karen E Gibbs, Anthony Petrick, Ian S Soriano, ASMBS Foregut Committee. Systematic review of management of gallbladder disease in patients undergoing minimally invasive bariatric surgery. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2020 Jan;16(1):158-164

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 31839526

View Full Text